The APOE ε4 allele, associated with Alzheimer disease (AD), elevates the risk of cognitive impairment when combined with diabetes.[33] The insulin-degrading enzyme (IDE) gene mediates amyloid-β and insulin breakdown, influencing cognitive outcomes.[34]. This evidence concerns the gene APOE and Alzheimer disease.